EUROFINS SCIENT (OTCMKTS:ERFSF - Get Free Report)'s stock price fell 5.9% during trading on Wednesday . The stock traded as low as $70.73 and last traded at $70.73. 628 shares traded hands during trading, a decline of 57% from the average session volume of 1,462 shares. The stock had previously closed at $75.17.
Wall Street Analysts Forecast Growth
Separately, Citigroup restated a "neutral" rating on shares of EUROFINS SCIENT in a research note on Friday, July 25th. One research analyst has rated the stock with a Strong Buy rating and five have issued a Hold rating to the company. According to data from MarketBeat, the company presently has a consensus rating of "Hold".
View Our Latest Analysis on ERFSF
EUROFINS SCIENT Stock Down 2.6%
The company has a quick ratio of 1.19, a current ratio of 1.26 and a debt-to-equity ratio of 0.77. The business has a 50 day moving average price of $75.47 and a 200-day moving average price of $69.25.
EUROFINS SCIENT Company Profile
(
Get Free Report)
Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. The company offers a portfolio of various analytical methods and tests to evaluate the safety, identity, composition, authenticity, origin, traceability, and purity of various products.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider EUROFINS SCIENT, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and EUROFINS SCIENT wasn't on the list.
While EUROFINS SCIENT currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
